Cannvas MedTech Inc. (“Cannvas” or the “Company”) (CSE: MTEC, Frankfurt: 3CM), a leading business technology company in the cannabis space, is pleased to announce the appointment of Elizabeth Moniz and Tom Loutskou to the newly formed Cannvas Education Advisory Panel. The Cannvas Education Advisory Panel will advise and set protocols for the broad educational spectrum that Cannvas.me offers to the medical cannabis industry.

“I am very pleased to welcome Elizabeth and Tom to the newly the formed Cannvas Education Advisory Panel,” said Steve Loutskou, Chief Operating Officer, Global Markets, Cannvas MedTech Inc. “The Education Advisory Panel will be made up of leading experts in the educational development field and instrumental in the way Cannvas.me delivers education to the medical cannabis world. Elizabeth (whose focus was Neuropsychology) and Tom (who has a Masters in Education) bring extensive education and training experience to our online medical cannabis platform. I look forward to working with the Panel as we roll out a robust medical cannabis educational program with the Cannvas.me platform.”

Cannvas.me is a scalable and comprehensive solution for the global medical cannabis community offering interactive tools and physician-backed content to audiences wishing to learn about healthcare through cannabis. Its Cannvas Academy, already guided by its Medical Advisory Board, will receive additional oversight and direction from the Education Advisory Panel, made up of highly qualified members from industry and government institutions.

A 20-year veteran in the education field as a teacher, mentor, and workshop leader, Elizabeth Moniz has extensive experience in health education. Through intensive research and relatable lesson plans, Elizabeth has helped hundreds of students thoroughly understand the implications of using a variety of substances. Elizabeth believes science-based information empowers people with the education needed to make healthy living choices. Elizabeth has an Honours Bachelor of Science Degree and a Post-Graduate Degree in Child Studies from the Ontario Institute for Studies in Education at the University of Toronto.

Tom Loutskou brings 17 years of teaching experience with a focus on physical and health education.  A vocal supporter of medicinal cannabis use for pain management and treatment of other ailments, Tom graduated from York Universitywith an Honours Bachelor of Science with Majors in Kinesiology and Biology and a Bachelor of Education, and holds a Masters of Education from Nipissing University.

About Cannvas MedTech Inc.
Cannvas MedTech is a leading business technology company in the cannabis space. We design and build customer-centric solutions that enable our partners to harness the power of data to truly understand their customers, industry, and key business drivers.

No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.

Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer’s future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.  For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted onwww.sedar.com.

Click here to connect with Cannvas MedTech Inc. (CSE: MTEC, Frankfurt: 3CM) for an Investor Presentation

Source: www.newswire.ca

Ayurcann Holdings Corp. (CSE: AYUR) (the “Company” or “Ayurcann”) an integrated Canadian extraction company specializing in the processing of cannabis and hemp for the production of oils and various derivative products, announces the granting of stock options and restricted share units.

The Company has announced that it has granted incentive stock options to directors, officers, employees and consultants of the Company to purchase an aggregate of 1,000,100 common shares under the Company’s Stock Option Plan. Each option is exercisable at a price of $0.16 per common share, expires three years from the date of grant and vest six months from the date of the grant.

Keep reading... Show less

A planned business merger between two leading cannabis producers hit a small delay this week as a critical vote got moved.

Meanwhile, a cannabis retail operator elected to celebrate 420 by auctioning a cannabis-themed digital art piece using blockchain technology.

Keep reading... Show less

Partnerships with Minardi Law , Minorities for Medical Marijuana, CultivatED, and the Georgia Justice Project will include clinics and virtual events across Florida , Georgia , and Massachusetts

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today a series of expungment clinics located throughout south and central Florida as well as virtual events in Georgia and Massachusetts . The clinics are part of the Company’s celebration of the 50 th anniversary of 420.

Keep reading... Show less

Seth Rogen’s New Cannabis Brand are Now Available at Apothecarium Dispensaries in San Francisco , Berkeley and Capitola

The Apothecarium is offering cannabis from Houseplant, the cannabis lifestyle brand founded by Seth Rogen and Evan Goldberg at its five California dispensaries. The Apothecarium has three San Francisco locations (Castro, SOMA and Marina ) and one each in Berkeley and Capitola (outside of Santa Cruz ).

Keep reading... Show less